The present invention is related to novel 2-Amino-2-[8-(dimethyl carbamoyl)-8-aza-bicyclo[3.2.1]oct-3-yl]-exo-ethanoyl derivatives of the general formula (A), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
本发明涉及一种新型的2-
氨基-2-[8-(二甲基
氨基)-8-
氮杂双环[3.2.1]辛-3-基]-外消旋-乙酰衍
生物,其一般式为(A),其互变异构体,其立体异构体,其药学上可接受的盐,含有它们的制药组合物,制备上述化合物的方法,以及它们作为二肽基肽酶-IV(
DPP-IV)
抑制剂的用途,这些
抑制剂在治疗或预防疾病方面特别有用,特别是二型糖尿病,与糖尿病有关的其他并发症和其他涉及
DPP IV酶的病理条件。